{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:00Z","timestamp":1786981500120,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05328-y","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:23:44Z","timestamp":1762773824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-5058","authenticated-orcid":false,"given":"Mariana Mazzuia","family":"Guimar\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamilton","family":"Matushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"10","key":"5328_CR1","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s00381-023-06143-4","volume":"39","author":"L -Massimi","year":"2023","unstructured":"Massimi L, Palombi D, Musarra A, Bianchi F, Frassanito P, Tamburrini G, Di Rocco C (2023) Adamantinomatous craniopharyngioma: evolution in the management. Childs Nerv Syst 39(10):2613\u20132632. https:\/\/doi.org\/10.1007\/s00381-023-06143-4Epub 2023 Sep 20. PMID: 37728836; PMCID: PMC10613147","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"5328_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3390\/jcm14041101","volume":"14","author":"M -Javidialsaadi","year":"2025","unstructured":"Javidialsaadi M, Luy DD, Smith HL, Cecia A, Yang SD, Germanwala AV (2025) Advances in the management of craniopharyngioma: A narrative review of recent developments and clinical strategies. J Clin Med 14(4):1101. https:\/\/doi.org\/10.3390\/jcm14041101PMID: 40004632; PMCID: PMC11856613","journal-title":"J Clin Med"},{"key":"5328_CR3","doi-asserted-by":"publisher","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S, Craniopharyngioma (2019) Nat Rev Dis Primers. ;5(1):75. https:\/\/doi.org\/10.1038\/s41572-019-0125-9. PMID: 31699993","DOI":"10.1038\/s41572-019-0125-9"},{"key":"5328_CR4","doi-asserted-by":"publisher","first-page":"1326595","DOI":"10.3389\/fonc.2023.1326595","volume":"13","author":"A -Chen","year":"2023","unstructured":"Chen A, Ai M, Sun T (2023) Advances in the treatment of adamantinomatous craniopharyngioma: how to balance tumor control and quality of life in the current environment: a narrative review. Front Oncol 13:1326595. https:\/\/doi.org\/10.3389\/fonc.2023.1326595PMID: 38188294; PMCID: PMC10771305","journal-title":"Front Oncol"},{"key":"5328_CR5","doi-asserted-by":"publisher","unstructured":"Lohkamp LN, Kasper EM, Pousa AE, Bartels UK (2023) An update on multimodal management of craniopharyngioma in children. Front Oncol. ; 13:1149428. https:\/\/doi.org\/10.3389\/fonc.2023.1149428. PMID: 37213301; PMCID: PMC10196165","DOI":"10.3389\/fonc.2023.1149428"},{"issue":"3","key":"5328_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/nop\/npv029","volume":"3","author":"J -Varlotto","year":"2016","unstructured":"Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, Specht C, Sogge S, Nguyen D, Glantz M, Saw C, Upadhyay U, Moser R, Yunus S, Rava P, Fitzgerald T, Glanzman J, Sheehan J (2016) Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract 3(3):173\u2013187. https:\/\/doi.org\/10.1093\/nop\/npv029Epub 2015 Aug 30. PMID: 31386091; PMCID: PMC6668277","journal-title":"Neurooncol Pract"},{"issue":"8\u20139","key":"5328_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00381-005-1227-0","volume":"21","author":"A -C\u00e1ceres","year":"2005","unstructured":"C\u00e1ceres A (2005) Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst 21(8\u20139):705\u2013718","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"5328_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2213-8587(23)00162-6","volume":"11","author":"HW -Gan","year":"2023","unstructured":"Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA (2023) National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol 11(9):694\u2013706. https:\/\/doi.org\/10.1016\/S2213-8587(23)00162-6Epub 2023 Aug 4. PMID: 37549682","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"5328_CR9","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","volume":"161","author":"S -Sekine","year":"2002","unstructured":"Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161(6):1997\u20132001","journal-title":"Am J Pathol"},{"issue":"3","key":"5328_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/path.1562","volume":"203","author":"K -Kato","year":"2004","unstructured":"Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y (2004) Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203(3):814\u2013821","journal-title":"J Pathol"},{"issue":"9","key":"5328_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/jnen\/nlx061","volume":"76","author":"AM -Donson","year":"2017","unstructured":"Donson AM, Apps J, Griesinger AM, Amani V, Witt DA, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Kleinschmidt-DeMasters BK, Handler MH, Tan AC, Gore L, Virasami A, Gonzalez-Meljem JM, Jacques TS, Martinez-Barbera JP, Foreman NK, Hankinson TC (2017) Advancing treatment for pediatric craniopharyngioma Consortium. Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma. J Neuropathol Exp Neurol 76(9):779\u2013788","journal-title":"J Neuropathol Exp Neurol"},{"key":"5328_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3389\/fonc.2019.00791","volume":"9","author":"S -Grob","year":"2019","unstructured":"Grob S, Mirsky DM, Donson AM, Dahl N, Foreman NK, Hoffman LM, Hankinson TC, Mulcahy Levy JM (2019) Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma. Front Oncol 9:791","journal-title":"Front Oncol"},{"issue":"2","key":"5328_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11060-024-04899-6","volume":"172","author":"N -Joshi","year":"2025","unstructured":"Joshi N, Mueller S, Kline C (2025) Current clinical trials for craniopharyngiomas: what\u2019s on the horizon? J Neurooncol 172(2):281\u2013288. https:\/\/doi.org\/10.1007\/s11060-024-04899-6Epub 2025 Mar 5. PMID: 40042714; PMCID: PMC11937174","journal-title":"J Neurooncol"},{"key":"5328_CR14","doi-asserted-by":"publisher","first-page":"1225734","DOI":"10.3389\/fendo.2023.1225734","volume":"14","author":"E -de Vos-Kerkhof","year":"2023","unstructured":"de Vos-Kerkhof E, Buis DR, Lequin MH, Bennebroek CA, Aronica E, Hulleman E, Zwaveling-Soonawala N, van Santen HM, -van Schouten AYN (2023) Tocilizumab for the fifth progression of cystic childhood craniopharyngioma-a case report. Front Endocrinol (Lausanne) 14:1225734 PMID: 37886643; PMCID: PMC10598752","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5328_CR15","doi-asserted-by":"publisher","first-page":"CASE24410","DOI":"10.3171\/CASE24410","volume":"9","author":"LM -Webb","year":"2025","unstructured":"Webb LM, Okuno SH, Ransom RC, Van Gompel JJ, Humes AL, Sarkaria JN, Ruff MW (2025) Recurrent adamantinomatous craniopharyngioma stabilized with Tocilizumab and bevacizumab: illustrative case. J Neurosurg Case Lessons 9(2):CASE24410. https:\/\/doi.org\/10.3171\/CASE24410PMID: 39805108; PMCID: PMC11734617","journal-title":"J Neurosurg Case Lessons"},{"issue":"6","key":"5328_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1182\/blood-2018-05-846428","volume":"132","author":"A -Nellan","year":"2018","unstructured":"Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE (2018) Improved CNS exposure to Tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood 132(6):662\u2013666. https:\/\/doi.org\/10.1182\/blood-2018-05-846428Epub 2018 Jun 28. PMID: 29954750; PMCID: PMC6086204","journal-title":"Blood"},{"key":"5328_CR17","doi-asserted-by":"publisher","unstructured":"Prince EW, Hoffman LM, Vijmasi T, Dorris K, McWilliams JA, Jordan KR, Mirsky DM, Hankinson TC (2021) Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series. J Neurosurg Case Lessons. 1(19): CASE2150. https:\/\/doi.org\/10.3171\/CASE2150. PMID: 35854837; PMCID: PMC9245763","DOI":"10.3171\/CASE2150"},{"issue":"Suppl 1","key":"5328_CR18","first-page":"5730","volume":"132","author":"R -Gui","year":"2008","unstructured":"Gui R, Zhao J, Zu Y, Han L, Zhang Y, Yu F, Li Z, Zhao H, Fang B, Lin Q, Gao Q, Song Y, Zhou J, Liu D (2008) Successful treatment with intrathecal Tocilizumab (Il-6 antibody) for 2 cases of graft-versus host disease of the central nervous system after a second allogeneic HSCT from haploidentical donor. Blood 132(Suppl 1):5730","journal-title":"Blood"},{"key":"5328_CR19","doi-asserted-by":"crossref","unstructured":"Yucebay F, Maakaron J, Grana A, Jaglowski S, Roddy J (2020) Intrathecal chemotherapy: an alternative treatment strategy to prolonged corticosteroids for severe CART associated neurotoxicity. Biol Blood Marrow Transplant. 2020;26(3):S312","DOI":"10.1016\/j.bbmt.2019.12.390"},{"issue":"22","key":"5328_CR20","doi-asserted-by":"publisher","first-page":"e40356","DOI":"10.1016\/j.heliyon.2024.e40356","volume":"10","author":"R -Gui","year":"2024","unstructured":"Gui R, Li Z, Wang J, Zu Y, Zhang B, Zhao J, Song Y, Zhou J (2024) Intrathecal Tocilizumab for immune-mediated central nervous system complication after haploidentical hematopoietic stem cell transplantation in children: two case reports. Heliyon 10(22):e40356 2024.e40356. PMID: 39624308; PMCID: PMC11609442","journal-title":"Heliyon"},{"key":"5328_CR21","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Tocilizumabe [internet]. 2023 [acesso em 29 jul. 2025]. Dispon\u00edvel em: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/paf\/coronavirus\/medicamentos\/tocilizumabe"},{"issue":"6","key":"5328_CR22","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.3892\/mmr.2017.6538","volume":"15","author":"J -Zhou","year":"2017","unstructured":"Zhou J, Zhang C, Pan J, Chen L, Qi ST (2017) Interleukin\u20136 induces an epithelial\u2013mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep 15(6):4123\u20134131","journal-title":"Mol Med Rep"},{"key":"5328_CR23","doi-asserted-by":"publisher","unstructured":"Takano S, Akutsu H, Mizumoto M, Yamamoto T, Tsuboi K, Matsumura A (2015) Neuroendoscopy Followed by Radiotherapy in Cystic Craniopharyngiomas\u2013a Long-Term Follow-Up. World Neurosurg. ;84(5):1305-15.e1-2. https:\/\/doi.org\/10.1016\/j.wneu.2015.06.022. Epub 2015 Jun 20. PMID: 26100163","DOI":"10.1016\/j.wneu.2015.06.022"},{"issue":"9","key":"5328_CR24","doi-asserted-by":"publisher","first-page":"e18123","DOI":"10.7759\/cureus.18123","volume":"13","author":"MHA -Noureldine","year":"2021","unstructured":"Noureldine MHA, Khodmehr S, Sabahi M, Alikhani P, Jallo GI, Arjipour M (2021) Neuroendoscopic transventricular approach for cystic craniopharyngioma. Cureus 13(9):e18123. https:\/\/doi.org\/10.7759\/cureus.18123PMID: 34692333; PMCID: PMC8528039","journal-title":"Cureus"},{"key":"5328_CR25","doi-asserted-by":"publisher","unstructured":"Rachinger W, Oehlschlaegel F, Kunz M, Fuetsch M, Schichor C, Thurau S, Schopohl J, Seelos K, Tonn JC, Kreth FW (2017) Cystic Craniopharyngiomas: Microsurgical or Stereotactic Treatment? Neurosurgery. ;80(5):733\u2013743. https:\/\/doi.org\/10.1227\/NEU.0000000000001408. PMID: 27973392","DOI":"10.1227\/NEU.0000000000001408"},{"key":"5328_CR26","doi-asserted-by":"publisher","unstructured":"Hollon TC, Savastano LE, Altshuler D, Barkan AL, Sullivan SE (2018) Ventriculoscopic Surgery for Cystic Retrochiasmatic Craniopharyngiomas: Indications, Surgical Technique, and Short-Term Patient Outcomes. Oper Neurosurg (Hagerstown). 15(2):109\u2013119. https:\/\/doi.org\/10.1093\/ons\/opx220. PMID: 29048572","DOI":"10.1093\/ons\/opx220"},{"key":"5328_CR27","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1016\/j.wneu.2017.11.004","volume":"110","author":"L -Lauretti","year":"2018","unstructured":"Lauretti L, Legninda Sop FY, Pallini R, Fernandez E, D\u2019Alessandris QG (2018) Neuroendoscopic treatment of cystic craniopharyngiomas: A case series with systematic review of the literature. World Neurosurg 110:e367\u2013e373 Epub 2017 Nov 10. PMID: 29133004","journal-title":"World Neurosurg"},{"issue":"6","key":"5328_CR28","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s10143-021-01510-8","volume":"44","author":"C -Steiert","year":"2021","unstructured":"Steiert C, Grauvogel J, Roelz R, Demerath T, Schnell D, Beck J, Coenen VA, Reinacher PC (2021) Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction. Neurosurg Rev 44(6):3411\u20133420. https:\/\/doi.org\/10.1007\/s10143-021-01510-8Epub 2021 Mar 5. PMID: 33674982; PMCID: PMC8592958","journal-title":"Neurosurg Rev"},{"issue":"6","key":"5328_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/a-1934-9307","volume":"84","author":"A -Kulkarni","year":"2022","unstructured":"Kulkarni A, Konar S, Shukla D, Sadashiva N, Devi BI (2022) Transventricular endoscopic approach for cystic craniopharyngioma: case series. J Neurol Surg B Skull Base 84(6):591\u2013597. https:\/\/doi.org\/10.1055\/a-1934-9307PMID: 37854531; PMCID: PMC10581829","journal-title":"J Neurol Surg B Skull Base"},{"issue":"10","key":"5328_CR30","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/neuonc\/nox056","volume":"19","author":"JP -Kilday","year":"2017","unstructured":"Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, M\u00fcller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jim\u00e9nez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U (2017) Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro Oncol 19(10):1398\u20131407","journal-title":"Neuro Oncol"},{"issue":"12","key":"5328_CR31","doi-asserted-by":"publisher","first-page":"e31343","DOI":"10.1002\/pbc.31343","volume":"71","author":"MR -P\u00e9rez-Torres Lobato","year":"2024","unstructured":"P\u00e9rez-Torres Lobato MR, Morell M, Solano-P\u00e1ez P, Ortiz-Palacios M, Men\u00e1rgez \u00c1, Panesso M, V\u00e1zquez-G\u00f3mez F, Moreno-Carrasco J, Lassaletta \u00c1, Santa-Mar\u00eda V, Pavon-Mengual M, Quiroga E, Garc\u00eda-Ariza MA, Mora-Matilla M, Garrido-Colino C, Verd\u00fa-Amoros J, Nova-Lozano C, Vieito M, Cordero-Asanza EX, Clemente M, Ramos-Albiat M, de Morenas-Iglesias L, Moreno J, Llort L (2024) Long-term sequelae and quality of life after childhood-onset craniopharyngioma: results of a Spanish multicenter study. Pediatr Blood Cancer 71(12):e31343","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"5328_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1586\/14737175.2015.1100078","volume":"15","author":"HL -M\u00fcller","year":"2015","unstructured":"M\u00fcller HL (2015) Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother 15(11):1241\u20131244","journal-title":"Expert Rev Neurother"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05328-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:35:04Z","timestamp":1767702904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05328-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5328"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05328-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7421446\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national search committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}